About
0.82USD-0.04 -4.60%
Closed • Updated at 20:02 GMT+00:00Market Cap$29.00M
Volume121.3K
Beta1.79
RSI49.79
Neurosense Therapeutics Ltd. — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 28 2026
NeuroSense Announces Pricing of Insider-Led PIPE Financing
Apr 6 2026
NeuroSense Granted Brazilian Patent Covering PrimeC Composition
Apr 3 2026
NeuroSense Therapeutics Announces Receipt of Nasdaq Notifications Regarding Minimum Bid Price and Market Value Requirements
Mar 31 2026
NeuroSense Therapeutics Reports Year End 2025 Financial Results and Provides Business Update
Mar 24 2026
NeuroSense Advances Toward Key Regulatory Milestones with Strengthened Data Package and Near-Term Alzheimer's Readout
Recent Videos

A Glimpse into AI-Driven Healthcare Innovation
May 26, 2026

Social Start-up: NeuroSense
May 19, 2026

NeuroSense - an AI based early dementia detection system
May 13, 2026

NeuroSense - An AI Based early Alzheimer's risk prediction
Apr 27, 2026
Community Chat
Ask AI
Try asking
